G. Bellingan, F. Jacono, J. Bannard-Smith, D. Brealey, N. Meyer, D. Thickett, D. Young, A. Bentley, B. McVerry, R. Wunderink, K. Doerschug, C. Summers, M. Rojas, E. Jenkins, A. Ting
{"title":"一项评估多干细胞疗法(一种再生高级治疗药物产品(ATMP))治疗急性呼吸窘迫综合征(mu - ards)的1/2期研究的初步分析","authors":"G. Bellingan, F. Jacono, J. Bannard-Smith, D. Brealey, N. Meyer, D. Thickett, D. Young, A. Bentley, B. McVerry, R. Wunderink, K. Doerschug, C. Summers, M. Rojas, E. Jenkins, A. Ting","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7353","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":203218,"journal":{"name":"B14. LATE BREAKING CLINICAL TRIALS","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"30","resultStr":"{\"title\":\"Primary Analysis of a Phase 1/2 Study to Assess MultiStem® Cell Therapy, a Regenerative Advanced Therapy Medicinal Product (ATMP), in Acute Respiratory Distress Syndrome (MUST-ARDS)\",\"authors\":\"G. Bellingan, F. Jacono, J. Bannard-Smith, D. Brealey, N. Meyer, D. Thickett, D. Young, A. Bentley, B. McVerry, R. Wunderink, K. Doerschug, C. Summers, M. Rojas, E. Jenkins, A. Ting\",\"doi\":\"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7353\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":203218,\"journal\":{\"name\":\"B14. LATE BREAKING CLINICAL TRIALS\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"30\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"B14. LATE BREAKING CLINICAL TRIALS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7353\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"B14. LATE BREAKING CLINICAL TRIALS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7353","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Primary Analysis of a Phase 1/2 Study to Assess MultiStem® Cell Therapy, a Regenerative Advanced Therapy Medicinal Product (ATMP), in Acute Respiratory Distress Syndrome (MUST-ARDS)